The Food and Drug Administration is still considering whether a proposed genetically engineered fish is safe for consumers, the agency's top official said.
FDA Commissioner Margaret Hamburg said it was examining as many as 35,000 comments about the application on the salmon by Boston-based AquaBounty Technologies Inc, which applied for approval in the mid-1990s.
"We will be moving forward in a deliberate, science-driven way, reflecting all of the important inputs … as we consider this product application," Hamburg told the U.S. Senate's Health, Education, Labor and Pensions Committee during a hearing about the agency's current initiatives.
To read the rest of the story, please go to: Reuters
